
Indonesia - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact
You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).
By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.
Indonesia: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2022
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Indonesia
The Indonesian market for hormones, prostaglandins, thromboxanes and leukotrienes fell to $X in 2021, reducing by -X% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption showed a abrupt slump. Hormones, prostaglandins, thromboxanes and leukotrienes consumption peaked at $X in 2013; however, from 2014 to 2021, consumption failed to regain momentum.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from Indonesia
In 2021, shipments abroad of hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to X tons, rising for the third consecutive year after six years of decline. In general, exports showed a remarkable increase. The pace of growth appeared the most rapid in 2019 with an increase of X%. The exports peaked in 2021 and are expected to retain growth in the near future.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports skyrocketed to $X in 2021. Overall, exports enjoyed significant growth. The most prominent rate of growth was recorded in 2019 when exports increased by X%. The exports peaked in 2021 and are expected to retain growth in the immediate term.
Exports by Country
The UK (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from Indonesia, with a X% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to the UK exceeded the volume sent to the second major destination, Canada (X tons), sixfold. Malaysia (X tons) ranked third in terms of total exports with a X% share.
From 2012 to 2021, the average annual rate of growth in terms of volume to the UK totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Canada (+X% per year) and Malaysia (+X% per year).
In value terms, the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from Indonesia were Italy ($X), the UK ($X) and Malaysia ($X), together comprising X% of total exports.
The UK, with a CAGR of +X%, recorded the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2021, the average export price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, waning by -X% against the previous year. In general, the export price, however, enjoyed prominent growth. The growth pace was the most rapid in 2017 an increase of X%. As a result, the export price reached the peak level of $X per kg. From 2018 to 2021, the the average export prices remained at a somewhat lower figure.
Prices varied noticeably by the country of destination: the country with the highest price was Italy ($X per kg), while the average price for exports to Canada ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the UK (+X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into Indonesia
In 2021, overseas purchases of hormones, prostaglandins, thromboxanes and leukotrienes were finally on the rise to reach X tons after two years of decline. Overall, total imports indicated mild growth from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -X% against 2018 indices. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. As a result, imports attained the peak of X tons. From 2019 to 2021, the growth imports remained at a lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports expanded remarkably to $X in 2021. In general, imports, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 when imports increased by X%. As a result, imports attained the peak of $X. From 2014 to 2021, the growth imports remained at a lower figure.
Imports by Country
In 2021, China (X tons) constituted the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier to Indonesia, with a X% share of total imports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes imports from China exceeded the figures recorded by the second-largest supplier, Italy (X tons), threefold. The third position in this ranking was held by India (X tons), with a X% share.
From 2012 to 2021, the average annual growth rate of volume from China stood at -X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (+X% per year) and India (+X% per year).
In value terms, China ($X) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to Indonesia, comprising X% of total imports. The second position in the ranking was held by Italy ($X), with a X% share of total imports. It was followed by India, with an X% share.
From 2012 to 2021, the average annual growth rate of value from China totaled -X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (+X% per year) and India (+X% per year).
Import Prices by Country
In 2021, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per ton, increasing by X% against the previous year. Over the period under review, the import price, however, continues to indicate a pronounced descent. The pace of growth was the most pronounced in 2019 an increase of X%. The import price peaked at $X per ton in 2012; however, from 2013 to 2021, import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Spain ($X per ton), while the price for China ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (-X%), while the prices for the other major suppliers experienced a decline.
Source: IndexBox Platform
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2021 | 2007-2021 | 2022-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Indonesia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Making Data-Driven Decisions to Grow Your Business
A Quick Overview of Market Performance
Understanding the Current State of The Market and Its Prospects
Finding New Products to Diversify Your Business
Choosing the Best Countries to Establish Your Sustainable Supply Chain
Choosing the Best Countries to Boost Your Exports
The Latest Trends and Insights into The Industry
The Largest Import Supplying Countries
The Largest Destinations for Exports
The Largest Producers on The Market and Their Profiles
Recommended reports
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 22nd, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 8th, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, January 25th, 2022 @ 04:00 pm ET